Monthly Archives: September 2010
FDA Approves Pegloticase (Krystexxa) for Refractory Gout
Good news for patients with gout. The US Food and Drug Administration (FDA) has just approved a new agent, pegloticase (Krystexxa) for gout patients who are refractory to conventional therapy. The approval was based on data from 2 replicate, multicenter, … Continue reading
History of Gout is linked to an Increase Risk of Heart Failure Events
It has been known that gout increases the risk of ischemic heart disease and mortality. A new study showed that gout is also associated with an increase risk of heart-failure hospitalization and death. In Montreal, Quebec, Canadian researchers performed an … Continue reading
Lingzhi and San-Miao-San May Improve the Symptoms of Patients with Rheumatoid Arthritis (RA)
Last time, we reported the beneficial effect of a Chinese mushroom, Yunzhi, on cancer patients receiving chemotherapy. This time, we would like to share with you the immunomodulatory effect of another Chinese mushroom, Lingzhi, on patients with rheumatoid arthritis. RA … Continue reading
Drink Cranberry Juice to Prevent Urinary Tract Infection
Previously studies have suggested cranberry juice can fight against bacteria in Petri disk. A new study, presented at the national meeting of the American Chemical Society, added to the existing evidence by showing cranberry juice could reach the urinary tract … Continue reading
Water: A Secret Weapon to Lose Weight?
When I was a kid, my mom always told me not to drink water before a meal. She told me drinking water would fill up my stomach and made me eat less. I believed her words, but have never seen … Continue reading
How to Prevent Lung Cancer if You Are a Smoker?
If you are a smoker and would like to prevent lung cancer, you should consider eating a variety of fruit and vegetable. This piece of advice came from a new study published in the Aug 31 issue of the Cancer … Continue reading
A New Treatment Option for patients with Gastric Cancer
Gastric cancer is the fourth most commonly diagnosed cancer and the second most common cause of cancer-related deaths worldwide. Previous study has found that patients with operable disease have a 5-year survival rate of 36%. In patients with advanced or … Continue reading
Yunzhi-Danzhen Improves Immune System in Nasopharyngeal Cancer(NPC) Patients
Nasopharyngeal carcinoma is a prevalent tumor in Hong Kong. If you have nasopharyngeal cancer, that is a bad news. The good news is patients with early stage disease (Stage I and II disease) have a 5-year survival rate of more than 70%. … Continue reading